Atlas Trials

Evaluation and Modeling of the G-CSF Effect on the Evolution of Neutrophils During Chemotherapy Based on Eribulin

Clinical trial NCT02841722 · COMPLETED

Trial details

NCT number
NCT02841722
Sponsor
Centre Georges Francois Leclerc
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2015-12-03
Primary completion
2015-12-03
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.